Company Overview: M Pharmaceutical Inc.

Industry News

15 Oct

M Pharmaceutical, Inc. Engages Roy M. Kulick, MD as Clinical Development Advisor

VANCOUVER, BRITISH COLUMBIA–(Marketwired – Oct 15, 2015) – M Pharmaceutical, Inc.(CSE:MQ) (MPHMF) (T3F2.F), (the “Company”), a clinical-stage company developing innovative technologies for the monitoring and treatment of obesity, diabetes, and other gastroenterological indications, today announced the engagement of Roy M. Kulick, MD as Clinical Development Advisor. Dr. Kulick will prepare...

Read more

17 Sep

StockNewsNow.com Publishes New SNNLive Video Interview With M Pharmaceutical Inc.

LOS ANGELES, CA–(Marketwired – Sep 17, 2015) –  StockNewsNow.com, The Official MicroCap News Source™, today published an SNNLive Video Interview with Matthew Lehman, CEO of M Pharmaceutical Inc. (CSE: MQ) (OTCQB: MPHMF), a clinical-stage company developing technologies for the monitoring and treatment of obesity, diabetes, and other gastroenterological indications, according to...

Read more

15 Sep

SeeThruEquity Issues Update on M Pharmaceutical, Inc. (CSE: MQ; OTCQB: MPHMF)

NEW YORK, NY / ACCESSWIRE / September 15, 2015 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has issued an update on M Pharmaceutical, Inc. (CSE: MQ; OTCQB: MPHMF). The report is available here: MQ Update Note. SeeThruEquity...

Read more

10 Sep

M Pharmaceutical’s CEO Issues Letter to Shareholders

VANCOUVER, BRITISH COLUMBIA–(Marketwired – Sep 10, 2015) – M Pharmaceutical, Inc. (CSE:MQ)(MPHMF)(T3F2.F), (the “Company”), a clinical-stage company developing innovative technologies for the monitoring and treatment of obesity, diabetes, and other gastroenterological indications, today released the following letter to shareholders from the Company’s CEO, Matthew Lehman. Dear Shareholders, After my first week...

Read more

19 Aug

Matthew B. Lehman Appointed Chief Executive Officer of M Pharmaceutical, Inc.

VANCOUVER, BRITISH COLUMBIA–(Marketwired – Aug 19, 2015) – M Pharmaceutical, Inc. (CSE:MQ)(MPHMF)(T3F2.F), (the “Company“), a clinical-stage company developing innovative technologies for the monitoring and treatment of obesity, diabetes, and other gastroenterological indications, today announced the appointment of Matthew B. Lehman as President and Chief Executive Officer, effective September 1, 2015. Mr....

Read more

18 Aug

M Pharmaceutical to Open a Fully Owned Subsidiary in Sofia, Bulgaria

VANCOUVER, BRITISH COLUMBIA–(Marketwired – Aug 18, 2015) – M Pharmaceutical, Inc. (CSE:MQ) (MPHMF) (T3F2.F), (the “Company”), a clinical-stage company developing innovative technologies for the monitoring and treatment of obesity, diabetes, and other gastroenterological disorders, announced today that its Board of Directors has made a decision to open a fully owned subsidiary...

Read more

17 Aug

M PHARMACEUTICAL AND RISHENA ENTER INTO MANUFACTURING SUPPLY AGREEMENT FOR PRODUCTION OF TRIMTEC GASTRIC STIMULATION DEVICE

VANCOUVER, B.C., CANADA (17 August 2015) – M Pharmaceutical, Inc. (CSE:MQ, OTCQB: MPHMF, FWB:T3F2 ), (the “Company”), a clinical-stage company developing innovative technologies for the monitoring and treatment of obesity, diabetes, and other gastroenterological disorders, announced today that it has entered into a manufacturing supply agreement with Rishena Co.,...

Read more

17 Jul

Highly-Touted Gastrointestinal Surgeon and Metabolism Researcher Dr. Oliver F. Bathe Named Adviser to M Pharmaceutical, Inc.

Leader of the provincial gastrointestinal tumour team at the Tom Baker Cancer Centre at the University of Calgary joins an impressive Advisory Board for Canadian biomedical technology company focused on obesity and diabetes. M Pharmaceutical Inc., (CSE:MQ)(MPHMF)(T3F1.F) (the “Company”), a Canadian company committed to developing and commercializing innovative biomedical...

Read more

16 Jul

M Pharmaceutical Inc. Rebrands Itself to Better Reflect Growing Family of Biomedical Technologies.

New Corporate Identity Will Enhance Understanding of Biomedical Technologies Designed to Improve the Health of Those Affected by Obesity and Diabetes M Pharmaceutical Inc. (CSE:MQ)(MPHMF)(T3F1.F) (the “Company”), a Canadian company committed to developing and commercializing innovative biomedical technologies that improve the health and quality of life for people affected...

Read more

Page 1 of 212

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address